| miR-1289 and “Zipcode”-like sequence enrich mRNAs in microvesicles MF Bolukbasi, A Mizrak, GB Ozdener, S Madlener, T Ströbel, EP Erkan, ... Molecular Therapy-Nucleic Acids 1, 2012 | 393 | 2012 |
| Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth A Mizrak, MF Bolukbasi, GB Ozdener, GJ Brenner, S Madlener, EP Erkan, ... Molecular Therapy 21 (1), 101-108, 2013 | 366 | 2013 |
| Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer K Zhang, EP Erkan, S Jamalzadeh, J Dai, N Andersson, K Kaipio, ... Science advances 8 (8), eabm1831, 2022 | 107 | 2022 |
| A functional homologous recombination assay predicts primary chemotherapy response and long-term survival in ovarian cancer patients M Tumiati, S Hietanen, J Hynninen, E Pietilä, A Färkkilä, K Kaipio, ... Clinical Cancer Research 24 (18), 4482-4493, 2018 | 107 | 2018 |
| miQC: An adaptive probabilistic framework for quality control of single-cell RNA-sequencing data AA Hippen, MM Falco, LM Weber, EP Erkan, K Zhang, JA Doherty, ... PLoS computational biology 17 (8), e1009290, 2021 | 62 | 2021 |
| Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo EP Erkan, D Senfter, S Madlener, G Jungwirth, T Ströbel, N Saydam, ... Cancer gene therapy 24 (1), 38-44, 2017 | 54 | 2017 |
| Depletion of minichromosome maintenance protein 7 inhibits glioblastoma multiforme tumor growth in vivo EP Erkan, T Ströbel, G Lewandrowski, B Tannous, S Madlener, T Czech, ... Oncogene 33 (39), 4778-4785, 2014 | 45 | 2014 |
| Role of the microRNA-29 family in fibrotic skin diseases D Harmanci, EP Erkan, A Kocak, GG Akdogan Biomedical reports 6 (6), 599-604, 2017 | 42 | 2017 |
| miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo O Senol, TBM Schaaij-Visser, EP Erkan, C Dorfer, G Lewandrowski, ... Oncogene 34 (14), 1790-1798, 2015 | 41 | 2015 |
| A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids W Senkowski, L Gall-Mas, MM Falco, Y Li, K Lavikka, MC Kriegbaum, ... Developmental Cell 58 (12), 1106-1121. e7, 2023 | 36 | 2023 |
| miRNA signature of schwannomas: possible role (s) of “tumor suppressor” miRNAs in benign tumors EP Erkan, XO Breakefield, O Saydam Oncotarget 2 (3), 265, 2011 | 30 | 2011 |
| Circulating tumor biomarkers in meningiomas reveal a signature of equilibrium between tumor growth and immune modulation EP Erkan, T Ströbel, C Dorfer, M Sonntagbauer, A Weinhäusel, N Saydam, ... Frontiers in oncology 9, 1031, 2019 | 23 | 2019 |
| PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples A Häkkinen, K Zhang, A Alkodsi, N Andersson, EP Erkan, J Dai, K Kaipio, ... Bioinformatics 37 (18), 2882-2888, 2021 | 20 | 2021 |
| Cell division cycle 7-kinase inhibitor PHA-767491 hydrochloride suppresses glioblastoma growth and invasiveness Z Erbayraktar, B Alural, RS Erbayraktar, EP Erkan Cancer cell international 16, 1-10, 2016 | 20 | 2016 |
| Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer L He, D Bulanova, J Oikkonen, A Häkkinen, K Zhang, S Zheng, W Wang, ... Briefings in bioinformatics 22 (6), bbab272, 2021 | 16 | 2021 |
| Overexpression of minichromosome maintenance protein 10 in medulloblastoma and its clinical implications D Senfter, EP Erkan, E Özer, G Jungwirth, S Madlener, M Kool, T Ströbel, ... Pediatric blood & cancer 64 (12), e26670, 2017 | 13 | 2017 |
| Extracellular vesicles as novel delivery tools for cancer treatment E Pekcan Erkan, O Saydam Current Cancer Drug Targets 16 (1), 34-42, 2016 | 6 | 2016 |
| Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer IM Launonen, EP Erkan, I Niemiec, A Junquera, M Hincapie-Otero, ... bioRxiv, 2024 | 4 | 2024 |
| Extracellular vesicles as carriers of suicide mRNA and/or protein in cancer therapy EP Erkan, N Saydam, CC Chen, O Saydam Suicide Gene Therapy: Methods and Protocols, 87-96, 2019 | 4 | 2019 |
| A platform for efficient establishment, expansion and drug response profiling of high-grade serous ovarian cancer organoids W Senkowski, L Gall-Mas, MM Falco, Y Li, K Lavikka, MC Kriegbaum, ... bioRxiv, 2022.04. 21.489027, 2022 | 3 | 2022 |
Anna VähärautioPI, University of Helsinki在 helsinki.fi 的电子邮件经过验证
